European Psychiatry - Volume 33 - March 2016

766 / 812

S762 24th European Congress of Psychiatry / European Psychiatry 33S (2016) S349–S805
Introduction Infertility is not only a medical condition and its
impact in mental health is well established. Although most couples
facing fertility problems and the demands of medical treatment
are able to adjust, some of them may show psychological difficul-
ties with clinical relevance, such as depression and anxiety. The
Mindfulness Based Program for Infertility (MBPI) is a group inter-
vention designed for infertile women and data from its efficacy
study revealed impact in depressive symptoms reduction as well
as in internal and external shame, entrapment and defeat. Based
on the MBPI, a mindfulness app targeting infertile patients was
developed – the MindfulSpot.
Aims This study addresses the MindfulSpot development.
Methods TheMindfulSpot is a prototypemobile app, which seeks
to offer the chance of practicing mindfulness in a comfortable and
accessibleway. This app covers informative audio andwritten texts.
The audio contents correspond tomindfulness formal practices and
suggestions for informal practice, making possible its use through-
out different moments of the day. Beyond the practices mentioned
above, users are invited to explore the informative menu, includ-
ing information on the impact that infertility may have in several
aspects of the patients’ lives.
Results The efficacy of the MindfulSpot is still under analysis and
results are expected to be available soon.
Conclusions The MindfulSpot was designed as a medium for
training mindfulness skills and it includes useful information
regarding specific aspects of the emotional impact of infertility.
Additionally to its independent use, it may also be used as a support
tool of the MBPI.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV1295
Towards a gold standard for
internet-delivered programs in
behavioral and mental health
D. Richards ∗ Vigano . O’Callaghan ’Brien
J. Mooney onner
1 SilverCloud Health, Clinical Research & Innovation, Dublin, Ireland
2 Trinity College Dublin, School of Psychology, Dublin, Ireland
3 SilverCloud Health, Chief Security Officer, Dublin, Ireland
∗ Corresponding author.
Introduction Technological innovation has been pervasive and
has touched almost every aspect of modern life, including the deliv-
ery of behavioural and mental heath care. As telehealth expands,
internet interventions are particularly interesting as a medium of
delivering effective care. However, standards are required to help
informhealthcare policymakers, providers, clinicians and patients.
Objective Move towards outlining a gold standard for internet-
delivered behavioural and mental health interventions.
Aims Contribute and build upon existing standards and guide-
lines for the practice of telehealth, but to now extend these to
include internet-delivered interventions.
Methods Drawing from research, experience and practice, the
authors propose a matrix for the evaluation of what might be
considered a gold standard for internet-delivered behavioural and
mental health interventions.
Results Seven elements are proposed and considered aspects
of what would constitute a gold standard and they include,
the use of evidence-based and empirically supported content,
robust, engaging, secure and responsive technologies, shaped by
behavioural health subject matter experts, employ user-centred
design and development principles, have a focus on accountable
care-achieving clinical outcomes, have research and evaluation that
supports its effectiveness, and a well developed implementation
science and support.
Conclusion The paper proposes some characteristics that could
compose a gold standard for internet-delivered interventions for
behavioural and mental health care. The contribution is neither
exhaustive nor conclusive, but offers an invitation to the discussion.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV1296
mHealth in mental health: What do
the users think about it?
J.M. Sengelen ∗ Banea
Centre Hospitalier de Rouffach, pôle 2/3, Rouffach, France
∗ Corresponding author.
There is currently a major trend for e-health and the first men-
tal health applications for smartphones are now released. Patients
and health care professionals are still struggling to position them-
selves in relation to these new approaches. So, we wanted to know
more about the involvement of mental health users and their care
providers in mobile health (mHealth) technologies. We needed to
understand their expectations and their reluctances. For achieving
this purpose, we carried out an online survey for mental health
users (n = 108). It turns out that people who responded to this sur-
vey are well equipped with smartphones and are experienced in
using mobile apps. They expect from professionals an advisory role
in relation to e-health. The major interest lies in practical, concrete
applications and the main reluctance is about management, transit
and storage of data. It is necessary to involve mental health users
and health care professionals together in order to develop these
new tools. To achieve this, health care professionals must continue
to invest themselves in the use and understanding of m-Health
tools.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
Treatment practice
EV1297
Drug-induced tardive dyskinesia: A
case report
I. Abida∗, I. Baati , S. Omri , R. Sallemi , J. Masmoudi
CHU Hédi Chaker, Sfax, Tunisia
∗ Corresponding author.
Introduction Tardive dyskinesia (TD) is a serious medical condi-
tion that affects a significant proportion of patients treated with
antipsychotic agents.
Objective To report a patient who developed tardive dyskinesia
after initiation of antipsychotic and antidepressant treatment.
Case report Miss H. is 24-year-old Tunisianwomanwho had been
diagnosed with bipolar disorder 6 years ago. She received various
drugs: olanzapine, haloperidol, amisulpride, sertraline, paroxetine,
etc. On November 2013, she first complained of hand tremor and
then developed severe dystonia of the trunk and chorea. A series
of laboratory tests was performed after the onset of these invol-
untary movements. It included complete blood count, liver, renal,
and thyroid function tests, blood prolactin level, blood glucose
level, blood copper level and ceruloplasmin level. A brain MRI
was also performed. These examinations showed no specific find-
ings. The diagnosis of TD was presumed. The patient was first
treated with amisulpride, lorazepam, avlocardyl and piracetam
until May 2014. Then, amisulpride was substituted by olanzapine